Reference health

T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis

https://doi.org/10.1038/mi.2015.20
CiteStamped reference-health badge
78/78 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 78 checked references that resolve
resolves10.1056/NEJM200212123472418
Inflammatory Bowel Disease
resolves10.1056/NEJMra0804647
Inflammatory Bowel Disease
resolves10.1038/nm.2505
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut
resolves10.1016/B978-0-12-381300-8.00002-2
Innate Signaling Networks in Mucosal IgA Class Switching
resolves10.1038/nri2378
Vitamin effects on the immune system: vitamins A and D take centre stage
resolves10.1084/jem.170.4.1415
Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production.
resolves10.1016/S1074-7613(00)00044-3
TGF-β Receptor Controls B Cell Responsiveness and Induction of IgA In Vivo
resolves10.1111/j.1600-065X.2011.01018.x
Regulatory T cells and Foxp3
resolves10.1016/0092-8674(93)80068-P
Interleukin-10-deficient mice develop chronic enterocolitis
resolves10.1016/j.immuni.2008.02.017
Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
resolves10.1016/j.immuni.2014.03.012
Macrophage-Restricted Interleukin-10 Receptor Deficiency, but Not IL-10 Deficiency, Causes Severe Spontaneous Colitis
resolves10.1016/j.immuni.2011.03.018
Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
resolves10.1016/j.immuni.2011.01.020
Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3− and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
resolves10.1038/ni904
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
resolves10.1126/science.1079490
Control of Regulatory T Cell Development by the Transcription Factor <i>Foxp3</i>
resolves10.1084/jem.20030152
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor <i>Foxp3 </i>
resolves10.4049/jimmunol.178.7.4022
Cutting Edge: IL-2 Is Essential for TGF-β-Mediated Induction of Foxp3+ T Regulatory Cells
resolves10.4049/jimmunol.0802535
A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis
resolves10.1073/pnas.0812681106
A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota
resolves10.1007/s13258-012-0062-4
TGF-β and BAFF derived from CD4+CD25+Foxp3+ T cells mediate mouse IgA isotype switching
resolves10.1016/0016-5085(90)90290-H
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
resolves10.1016/0016-5085(94)90803-6
Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
resolves10.1016/j.intimp.2010.11.034
The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis
resolves10.1084/jem.186.10.1749
Suppressive Role of B Cells in Chronic Colitis of  T Cell Receptor α Mutant Mice
resolves10.1002/ibd.21769
B Cells Exposed to Enterobacterial Components Suppress Development of Experimental Colitis
resolves10.4049/jimmunol.170.4.1707
B Cell Developmental Requirement for the <i>G</i> α <i>i2</i> Gene
resolves10.1016/j.ajpath.2010.10.022
IL-10–Producing Regulatory B10 Cells Inhibit Intestinal Injury in a Mouse Model
resolves10.1016/j.jaut.2014.01.032
IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut
resolves10.4049/jimmunol.1103354
A Novel IL-10–Independent Regulatory Role for B Cells in Suppressing Autoimmunity by Maintenance of Regulatory T Cells via GITR Ligand
resolves10.4049/jimmunol.0900185
Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation
resolves10.3109/08916934.2012.665523
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis
resolves10.1126/science.288.5474.2222
A Primitive T Cell-Independent Mechanism of Intestinal Mucosal IgA Responses to Commensal Bacteria
resolves10.1136/gut.2006.099861
Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule
resolves10.1093/intimm/5.11.1461
Phenotypically distinct subsets of CD4<sup>+</sup> T cells induce or protect from chronic intestinal inflammation in C. B-17 <i>scid</i> mice
resolves10.1016/S1074-7613(02)00274-1
Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation
resolves10.4049/jimmunol.178.6.3447
B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis
resolves10.1016/j.immuni.2011.11.019
B Cell-Intrinsic MyD88 Signaling Prevents the Lethal Dissemination of Commensal Bacteria during Colonic Damage
resolves10.1186/1476-9255-2-13
Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector
resolves10.1080/00365529850171080
Role of Interleukin-10 in a Murine Model of Dextran Sulfate Sodium-Induced Colitis
resolves10.1021/mp100331r
Treatment of Mice with Dextran Sulfate Sodium-Induced Colitis with Human Interleukin 10 Secreted by Transformed<i>Bifidobacterium longum</i>
resolves10.1016/1074-7613(95)90157-4
Abnormal B lymphocyte delevopment, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
resolves10.1007/s10620-010-1240-3
Induction and Activation of Adaptive Immune Populations During Acute and Chronic Phases of a Murine Model of Experimental Colitis
resolves10.4161/gmic.1.6.13727
Microbiota
resolves10.1084/jem.184.6.2271
Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice
resolves10.1038/ni833
B cells regulate autoimmunity by provision of IL-10
resolves10.4049/jimmunol.1001307
Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis
resolves10.4049/jimmunol.1200936
IL-10 Produced by Induced Regulatory T Cells (iTregs) Controls Colitis and Pathogenic Ex-iTregs during Immunotherapy
resolves10.1007/s10875-009-9345-1
Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease
resolves10.1084/jem.20091618
OX40 is required for regulatory T cell–mediated control of colitis
resolves10.4049/jimmunol.177.9.5852
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
resolves10.1002/eji.201243154
On the road to tolerance — Generation and migration of gut regulatory T cells
resolves10.1002/eji.200737296
Reciprocal generation of Th1/Th17 and T<sub>reg</sub> cells by B1 and B2 B cells
resolves10.1002/eji.200838201
Resting B cells expand a CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Treg population <i>via</i> TGF‐β3
resolves10.4049/jimmunol.1100284
Mice Lacking Endogenous IL-10–Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells
resolves10.1126/scitranslmed.3005407
CD19 <sup>+</sup> CD24 <sup>hi</sup> CD38 <sup>hi</sup> B Cells Maintain Regulatory T Cells While Limiting T <sub>H</sub> 1 and T <sub>H</sub> 17 Differentiation
resolves10.1165/rcmb.2011-0246OC
Regulatory T Cells Induced by Mucosal B Cells Alleviate Allergic Airway Hypersensitivity
resolves10.4049/jimmunol.169.9.4712
Cutting Edge: CD4+CD25+ Regulatory T Cells Suppress Antigen-Specific Autoreactive Immune Responses and Central Nervous System Inflammation During Active Experimental Autoimmune Encephalomyelitis
resolves10.4049/jimmunol.0904044
TGF-β–Induced Myelin Peptide-Specific Regulatory T Cells Mediate Antigen-Specific Suppression of Induction of Experimental Autoimmune Encephalomyelitis
resolves10.1093/intimm/dxh029
IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells
resolves10.1097/MIB.0b013e31829c32dd
Therapeutic Evaluation of Ex Vivo-Generated Versus Natural Regulatory T-cells in a Mouse Model of Chronic Gut Inflammation
resolves10.1155/2014/973609
CD20+ B Cell Depletion in Systemic Autoimmune Diseases: Common Mechanism of Inhibition or Disease-Specific Effect on Humoral Immunity?
resolves10.1056/NEJMoa0706383
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
resolves10.1002/ana.21363
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
resolves10.1136/gut.2010.225482
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
resolves10.1517/14712598.2014.885945
New biologic therapeutics for ulcerative colitis and Crohn's disease
resolves10.1002/ibd.20215
Exacerbation of ulcerative colitis after rituximab salvage therapy
resolves10.1136/gut.2007.138305
Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves’ disease
resolves10.1542/peds.2009-3395
Severe Ulcerative Colitis After Rituximab Therapy
resolves10.1016/j.pharma.2011.06.005
La colite ulcérative : une conséquence exceptionnelle après traitement par rituximab
resolves10.1053/gast.2003.50081
Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease
resolves10.3899/jrheum.100818
Cytomegalovirus Colitis and Hypo-IgG After Rituximab Therapy for Rheumatoid Arthritis
resolves10.1097/RHU.0b013e31820e715c
Colitis Associated With Active Systemic Lupus Erythematosus Successfully Treated With Rituximab
resolves10.1007/BF01303184
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin
resolves10.1038/nprot.2007.41
Chemically induced mouse models of intestinal inflammation
resolves10.1158/0008-5472.CAN-12-4184
Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
resolves10.1371/journal.pone.0054712
Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice
resolves10.4049/jimmunol.173.10.6346
Helminth Infection Protects Mice from Anaphylaxis via IL-10-Producing B Cells
The 2 references without a DOI — listed, not checked
no DOI — not checkedClinicopathologic study of dextran sulfate sodium experimental murine colitis
no DOI — not checkedIsolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch, and lamina propria cells
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1038/mi.2015.20"><img src="https://citestamp.com/citestamped/10.1038/mi.2015.20/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1038/mi.2015.20/badge.svg)](https://citestamp.com/citestamped/10.1038/mi.2015.20)